Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Dyadic International, Inc. (DYAI)

1.72   -0.12 (-6.52%) 09-24 15:40
Open: 1.79 Pre. Close: 1.84
High: 1.8 Low: 1.67
Volume: 32,230 Market Cap: 49(M)
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.8 - 1.81 1.81 - 1.82
Low: 1.65 - 1.66 1.66 - 1.67
Close: 1.7 - 1.72 1.72 - 1.74

Technical analysis

as of: 2022-09-23 4:23:36 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.85     One year: 3.41
Support: Support1: 1.66    Support2: 1.38
Resistance: Resistance1: 2.44    Resistance2: 2.92
Pivot: 2.25
Moving Average: MA(5): 1.82     MA(20): 2.35
MA(100): 2.64     MA(250): 3.3
MACD: MACD(12,26): -0.3     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 5     %D(3): 4.3
RSI: RSI(14): 19.9
52-week: High: 5.46  Low: 1.66
Average Vol(K): 3-Month: 38 (K)  10-Days: 60 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ DYAI ] has closed above bottom band by 10.5%. Bollinger Bands are 110.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Headline News

Wed, 21 Sep 2022
After a 24% dip, insiders are undoubtedly glad they sold Dyadic International, Inc. (NASDAQ:DYAI) - Simply Wall St

Tue, 13 Sep 2022
Dyadic Updates Market on Recent Scientific Achievements - Dyadic International (NASDAQ:DYAI) - Benzinga

Fri, 09 Sep 2022
Will Dyadic International, Inc. (DYAI) Outperform the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Thu, 08 Sep 2022
Dyadic to Present at Upcoming Industry and Investor Events in September - GlobeNewswire

Wed, 10 Aug 2022
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments - GlobeNewswire

Mon, 09 May 2022
Dyadic Announces Successful Toxicology Data Published in “Toxicologic Pathology” - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 28 (M)
Shares Float 19 (M)
% Held by Insiders 29.3 (%)
% Held by Institutions 14 (%)
Shares Short 315 (K)
Shares Short P.Month 400 (K)

Stock Financials

EPS -0.44
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.47
Profit Margin (%) 0
Operating Margin (%) -585.4
Return on Assets (ttm) -38.8
Return on Equity (ttm) -63.8
Qtrly Rev. Growth -29.8
Gross Profit (p.s.) 0.01
Sales Per Share 0.08
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -12 (M)
Levered Free Cash Flow -7 (M)

Stock Valuations

PE Ratio -3.93
PEG Ratio 0
Price to Book value 3.58
Price to Sales 21.16
Price to Cash Flow -4.22

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.